Heartburn Drug Zantac Pulled From Store Shelves Amid Cancer Concerns

NEW YORK (CBSNewYork) - A popular heartburn drug is being pulled from store shelves amid growing concerns it could cause cancer.

Drug-maker Sanofi says it's recalling Zantac in the United States and Canada.

The Food and Drug Administration is investigating a study from a Connecticut-based online pharmacy that the drug contains a probable carcinogen called NDMA.

The FDA has not recommended people stop taking Zantac, but advise people to talk to their doctors to switch medications.

For more information, see the Zantac website.